Trials (Oct 2021)

Electronic early notification of sepsis in hospitalized ward patients: a study protocol for a stepped-wedge cluster randomized controlled trial

  • Yaseen M. Arabi,
  • Abdulmohsen Alsaawi,
  • Mohammed Al Zahrani,
  • Ali M. Al Khathaami,
  • Raed H. AlHazme,
  • Abdullah Al Mutrafy,
  • Ali Al Qarni,
  • Ahmed Al Shouabi,
  • Eman Al Qasim,
  • Sheryl Ann Abdukahil,
  • Fawaz K. Al-Rabeah,
  • Huda Al Ghamdi,
  • Ebtisam Al Ghamdi,
  • Mariam Alansari,
  • Khadega A. Abuelgasim,
  • Abdulaleem Alatassi,
  • John Alchin,
  • Hasan M. Al-Dorzi,
  • Abdulaziz A. Ghamdi,
  • Fahad Al-Hameed,
  • Ahmad Alharbi,
  • Mohamed Hussein,
  • Wasil Jastaniah,
  • Mufareh Edah AlKatheri,
  • Hassan AlMarhabi,
  • Hani T. Mustafa,
  • Joan Jones,
  • Saad Al-Qahtani,
  • Shaher Qahtani,
  • Ahmad S. Qureshi,
  • Salih Bin Salih,
  • Nahar Alselaim,
  • Nabiha Tashkandi,
  • Ramesh Kumar Vishwakarma,
  • Emad AlWafi,
  • Ali H. Alyami,
  • Zeyad Alyousef,
  • for the SCREEN Trial Group

DOI
https://doi.org/10.1186/s13063-021-05562-5
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background To evaluate the effect of screening for sepsis using an electronic sepsis alert vs. no alert in hospitalized ward patients on 90-day in-hospital mortality. Methods The SCREEN trial is designed as a stepped-wedge cluster randomized controlled trial. Hospital wards (total of 45 wards, constituting clusters in this design) are randomized to have active alert vs. masked alert, 5 wards at a time, with each 5 wards constituting a sequence. The study consists of ten 2-month periods with a phased introduction of the intervention. In the first period, all wards have a masked alert for 2 months. Afterwards the intervention (alert system) is implemented in a new sequence every 2-month period until the intervention is implemented in all sequences. The intervention includes the implementation of an electronic alert system developed in the hospital electronic medical records based on the quick sequential organ failure assessment (qSOFA). The alert system sends notifications of “possible sepsis alert” to the bedside nurse, charge nurse, and primary medical team and requires an acknowledgment in the health information system from the bedside nurse and physician. The calculated sample size is 65,250. The primary endpoint is in-hospital mortality by 90 days. Discussion The trial started on October 1, 2019, and is expected to complete patient follow-up by the end of October 2021. Trial registration ClinicalTrials.gov NCT04078594 . Registered on September 6, 2019

Keywords